Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTangible Book ValueTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Operating Leases (2022 - 2025)

Historic Operating Leases for NewGenIvf (NIVF) over the last 4 years, with Q3 2025 value amounting to $298.1 billion.

  • NewGenIvf's Operating Leases changed N/A to $298.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $298.1 billion, marking a year-over-year change of. This contributed to the annual value of $10.2 billion for FY2024, which is 859889646.16% up from last year.
  • Per NewGenIvf's latest filing, its Operating Leases stood at $298.1 billion for Q3 2025.
  • In the past 5 years, NewGenIvf's Operating Leases registered a high of $298.1 billion during Q3 2025, and its lowest value of $118979.0 during Q4 2023.
  • Moreover, its 4-year median value for Operating Leases was $297980.0 (2025), whereas its average is $61.7 billion.
  • In the last 5 years, NewGenIvf's Operating Leases plummeted by 5087.31% in 2023 and then skyrocketed by 859889646.16% in 2024.
  • Over the past 4 years, NewGenIvf's Operating Leases (Quarter) stood at $242187.0 in 2022, then tumbled by 50.87% to $118979.0 in 2023, then skyrocketed by 8598896.46% to $10.2 billion in 2024, then skyrocketed by 2813.51% to $298.1 billion in 2025.
  • Its last three reported values are $298.1 billion in Q3 2025, $297980.0 for Q2 2025, and $10.2 billion during Q4 2024.